Lexaria Bioscience Corp.
LEXX
$0.58
-$0.10-14.96%
NASDAQ
| 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.70M | -3.79M | -2.71M | -2.70M | -2.18M |
| Total Depreciation and Amortization | 28.60K | 38.00K | 9.20K | 40.00K | 24.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 348.70K | 511.20K | 165.30K | 114.90K | 94.20K |
| Change in Net Operating Assets | -323.90K | -344.10K | 1.04M | -177.20K | 174.10K |
| Cash from Operations | -2.64M | -3.58M | -1.50M | -2.73M | -1.89M |
| Capital Expenditure | 0.00 | 0.00 | 0.00 | -24.60K | -43.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -157.90K | -19.40K | -27.90K | -13.20K | -26.60K |
| Cash from Investing | -157.90K | -19.40K | -27.90K | -37.80K | -69.60K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 1.69M | 11.70K | 4.35M | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 0.00 | 1.69M | 11.70K | 4.35M | 0.00 |
| Foreign Exchange rate Adjustments | 10.70K | 37.20K | -95.30K | -3.20K | 2.10K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.79M | -1.88M | -1.61M | 1.58M | -1.96M |